Shutdown-Delayed NIH Meeting Races to Fund Disease Research
Published Date: 11/28/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding a closed virtual meeting on December 18-19, 2025, to review important grant applications about infectious diseases. This meeting was delayed due to a government shutdown but is now urgent to keep vital health research funding on track. Scientists and researchers waiting on NIH grants will be affected by this quick rescheduling.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Urgent Rescheduling of NIH Grant Review
The NIH review meeting for infectious disease grant applications is being held urgently on December 18-19, 2025 after a 43-day government shutdown delayed it. The meeting was published less than 15 days before the date so evaluations can be submitted to national advisory councils for timely funding recommendations.
Closed Meeting Protects Applicant Confidentiality
The December 18-19, 2025 NIH review meeting will be closed to the public because discussions could disclose confidential trade secrets or personal information in grant applications. This keeps applicants' patentable material and personal data private during the evaluation process.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
2026-19804, Submission for OMB Review; 30-Day Comment Request; Generic Clearance for NIH Citizen Science and Crowdsourcing Projects (Office of the Director)
The NIH is asking for approval to keep collecting info from citizen science and crowdsourcing projects, making it easier to gather public input on health research. This affects anyone involved in these projects and invites comments by October 28, 2026. No new costs or big changes, just a smooth way to keep the data flowing for better science!
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
2026-19706, Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants
The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!
2026-19431, Government-Owned Inventions; Availability for Licensing
The government is offering a new invention for licensing that makes stem cell transplants safer and less harsh, especially for leukemia patients and older folks. This tech uses a special protein to prepare patients for transplants without the tough side effects of chemo and radiation. Companies can start licensing this preclinical innovation now to help bring better treatments to market faster.
Previous / Next Documents
Previous: 2025-21501, Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Final Guidance
Starting in 2026, Medicare will negotiate lower prices for some expensive drugs to help save money for patients and the government. This new rule affects drug makers, who must follow price limits through 2028, including a first-ever renegotiation cycle. These changes aim to make medicines more affordable while protecting certain special drugs, with clear deadlines and rules set by CMS.
Next: 2025-21503, Center For Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 28, 2026, to review cancer research grant applications. These meetings are private to protect secret ideas and personal info. Researchers applying for grants and the NIH are the main players, with no new costs or deadlines announced.